AB AB Science S.A.
0.5370EUR-1.29%Mkt Cap: 56.34M $P/E: —Today
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cance…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.30BUSDP/E 25.0
$57.06BUSD
$46.10BUSDP/E 65.9
$38.70BUSDP/E 18.3
$28.27BUSDP/E 12.1
$28.80BUSDP/E 11.4
$23.23BUSDP/E 19.4
$20.22BUSD
$14.24BUSDP/E 109.4
$14.55BUSDP/E 21.0
$12.60BUSDP/E 22.8
$11.06BUSD
$10.20BUSDP/E 29.2
$8.50BUSDP/E 18.4
$7.07BUSDP/E 42.3
$7.00BUSDP/E 109.9
$6.77BUSD
$6.53BUSDP/E 23.9
$5.83BUSDP/E 76.6
$4.21BUSDP/E 12.8
| Headline | Source | Time |
|---|---|---|
Older | ||
IIdeal Investisseur | ||
IIdeal Investisseur | ||
OOption Finance | ||